The government expects to reduce prices of the non-scheduled cancer drugs by up to 70% through the move and help patients save ₹2,500 crore annually.
Centre caps trade margins on non-scheduled cancer drugs at 30%, expects ₹2,500 crore annual savings for patients
Published ·
Keep reading
Related stories
HT evening news brief October 6: Rahul Gandhi-led Oppn march to ECI, Nobel Prize in Physics and more
